Evolution of the Average Target: Accor

Evolution of the Target Price: Accor

Changes in Analyst Recommendations: Accor

c8a.4g_l9d5_SNmNw9tC0SBIWcDkXD_xzH6JEVmbxEG33GY.rmCMsYo7e7T-ie0u6GUMDLqoDwi0mRz8Ww34iwbvrwmtSdeE5i85jNX0jg~733fca9adf6a0b2ef63a8db6e6dd21f2
09-04 Morgan Stanley Upgrades Accor to Overweight, Raises PT MT
09-04 Volkswagen shifts into second gear, with Porsche in its wake. Vivendi disappoints Zonebourse
07-02 AccorHotels: EPS cut (2025: -34.5%, 2026: -29.4%) Alphavalue
06-26 Jefferies Downgrades Accor to Hold, Lowers PT MT
06-26 Jefferies Downgrades Accor, Shares Pull Back Zonebourse
05-11 Citi reiterates Buy rating on Accor, lifts price target Zonebourse
04-29 Accor Kept at Buy as BofA Notes 'Solid' Q1 Activity Amid Market Uncertainties MT
04-24 AccorHotels: Middle East vulnerability beneath the surface of RevPAR resilience Alphavalue
04-24 Accor edges lower following mixed results Zonebourse
04-13 Berenberg: Accor 'Most Exposed' to Middle East Conflict Among Hotel Coverage; Price Target Cut MT
04-10 Berenberg trims price target on Accor Zonebourse
04-08 BofA Cuts Price Objective, Estimates for Accor Amid Middle East Conflict; Coverage Resumed at Buy MT
03-20 Oddo BHF remains bullish on Accor despite serious allegations from Grizzly Research Zonebourse
03-13 AlphaValue/Baader Europe Upgrades Accor to Buy Rating, Trims PT MT
03-05 Kepler Cheuvreux Upgrades Accor, Calls the Stock "Attractive" Zonebourse
03-04 Kepler Cheuvreux Upgrades Accor to Buy Rating MT
03-04 Accor Rebounds as Citi Raises Price Target Zonebourse
03-03 Amidst the current Middle East unrest Alphavalue
02-24 AccorHotels: Buoyant operations vs. lackluster earnings; Buyback hinges on Essendi exit Alphavalue
02-20 Europe research roundup - Accor, Jost Werke, Dassault Systemes RE
01-28 AlphaValue/Baader Europe Upgrades Accor to Add, Boosts PT MT
01-16 Jefferies Expects Strong Q4 RevPAR for Accor Zonebourse
01-16 Jefferies Reiterates Buy Recommendation on Accor Ahead of Earnings Release Zonebourse
12-30 AlphaValue/Baader Europe Trims Accor PT, Maintains Add Rating MT
12-17 BofA Boosts Accor Price Objective With "Top Buy" Label on Potential for Essendi Stake Sale, Buybacks MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.16%
+14.82%
+14.94%
+6.59%
+24.1%
+15.03%
+40.41%
+40.02%
+14.37%
+36.82%
Average +22.63%
Weighted average by Cap. +16.06%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
46.31EUR
Average target price
55.18EUR
Spread / Average Target
+19.16%
High Price Target
70.00EUR
Spread / Highest target
+51.16%
Low Price Target
41.00EUR
Spread / Lowest Target
-11.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!